Overview

Mitomycin-c Application for PRK

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of 5 seconds mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for patients with low myopia.
Phase:
N/A
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
Mitomycin
Mitomycins